<DOC>
	<DOCNO>NCT01715896</DOCNO>
	<brief_summary>The primary objective study explore efficacy mavrilimumab compare golimumab treatment adult subject 18-80 year age moderate-to-severe active rheumatoid arthritis ( RA ) inadequate response one conventional disease-modifying anti-rheumatic drug ( DMARDs ) and/or one two anti-tumor necrosis factor ( TNF ) agent ( exclude golimumab ) efficacy safety reason .</brief_summary>
	<brief_title>A Study Mavrilimumab Versus Anti Tumor Necrosis Factor Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description>Despite therapeutic improvement recent biologic agent approve rheumatoid arthritis ( RA ) , still significant unmet medical need treatment subject chronic disease achieve faster , complete response , high rate remission . The aim current study compare efficacy safety subcutaneous dose mavrilimumab market treatment RA ( golimumab ) 120 adult subject moderate-to-severe active RA inadequate response one two anti-TNF agent mavrilimumab . The design study exploratory formerly statistically power .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Age 18 80 year Written consent Diagnosis adult onset Rheumatoid Arthritis ( RA ) define 2010 American College Rheumatology European League Against Rheumatism ( ACR/EULAR ) classification criterion Moderately active disease define disease activity score 28 joint Creactive protein ( DAS28 [ CRP ] ) great equal ( &gt; = ) 3.2 screen DAS28 erythrocyte sedimentation rate ( ESR ) â‰¥ 3.2 Day 1 Inadequate response one conventional diseasemodifying antirheumatic drug ( DMARDs ) At least 4 swollen joint Inadequate response one two antiTNF agent study comparator , define protocol Receiving oral injectable methotrexate , define protocol . A rheumatic autoimmune disease inflammatory joint disease RA Previous treatment biologic therapy antiTNF RA Treatment DMARDs nonsteroidal antiinflammatory drug ( NSAIDs ) , define protocol . Medical history define protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Golimumab</keyword>
	<keyword>Mavrilimumab</keyword>
</DOC>